Antibiotic use and the development of inflammatory bowel disease
Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden Summary Background Use of...
top of page
The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
eDoctor In
Nov 1, 2020
Systematic Review on Inflammatory Bowel Disease Patients with Coronavirus Disease 2019
Systematic Review on Inflammatory Bowel Disease Patients with Coronavirus Disease 2019: It Is Time to Take Stock Background & Aims Data...
0
eDoctor In
Sep 6, 2020
Two-third of IBD patients relapse within 1 year of Vedolizumab discontinuation and re-treatment ...
Two-third of IBD patients relapse within 1 year of Vedolizumab discontinuation and re-treatment is effective in two-third of patients...
0
eDoctor In
Sep 5, 2020
Combination of NUDT15 genotyping and 6-thioguinine levelscan better predict leucopenia in NUDT15 ...
Combination of NUDT15 genotyping and 6-thioguinine levelscan better predict leucopenia in NUDT15 intermediate metobolizers Kang B et al.,...
0
eDoctor In
Sep 4, 2020
In postoperative Crohn’s disease, an endoscopic score incorporating disease activity in ....
In postoperative Crohn’s disease, an endoscopic score incorporating disease activity in anastomotic site as well as neo-terminal ileum...
0
eDoctor In
Sep 3, 2020
In case of immune-mediated loss of response to a first anti-TNF
In case of immune-mediated loss of response to a first anti-TNF, azathioprine should be used in combination with the second anti-TNF...
0
eDoctor In
Sep 2, 2020
Induction of deep remission at 1 year in early, biologic naive Crohn’s disease protects against ....
Induction of deep remission at 1 year in early, biologic naive Crohn’s disease protects against disease progression regardless of tight...
0
Test Profile
Aug 6, 2020
Journal of Crohn’s Colitis , July 2020
Two-third of IBD patients relapse within 1 year of Vedolizumab discontinuation and re-treatment is effective in two-third of patients Pal...
0
Test Profile
Aug 6, 2020
Alimentary pharmacology and Therapeutics, August 2020
Combination of NUDT15 genotyping and 6-thioguinine levelscan better predict leucopenia in NUDT15 intermediate metobolizers Pal P,...
0
bottom of page